These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8636265)

  • 41. Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis.
    Lane NE; Sanchez S; Genant HK; Jenkins DK; Arnaud CD
    Osteoporos Int; 2000; 11(5):434-42. PubMed ID: 10912846
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum immunoreactive bone sialoprotein as a new marker of bone turnover in metabolic and malignant bone disease.
    Seibel MJ; Woitge HW; Pecherstorfer M; Karmatschek M; Horn E; Ludwig H; Armbruster FP; Ziegler R
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3289-94. PubMed ID: 8784085
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Measurement of bone collagen degradation in hyperthyroidism and during thyroxine replacement therapy using pyridinium cross-links as specific urinary markers.
    Harvey RD; McHardy KC; Reid IW; Paterson F; Bewsher PD; Duncan A; Robins SP
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1189-94. PubMed ID: 2026741
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment.
    Garnero P; Shih WJ; Gineyts E; Karpf DB; Delmas PD
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1693-700. PubMed ID: 7989477
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rapid bone loss is associated with increased levels of biochemical markers.
    Ross PD; Knowlton W
    J Bone Miner Res; 1998 Feb; 13(2):297-302. PubMed ID: 9495524
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effects of sulphasalazine on urinary excretion of the hydroxypyridinium crosslinks of collagen in patients with rheumatoid arthritis.
    Dílek K; Alí I; Göksal K; Hüseyin T; Güner T
    Yonsei Med J; 2002 Aug; 43(4):435-40. PubMed ID: 12205730
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantitation of biochemical markers of bone resorption following strontium-89-chloride therapy for metastatic prostatic carcinoma.
    Papatheofanis FJ
    J Nucl Med; 1997 Aug; 38(8):1175-9. PubMed ID: 9255144
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Determination of galactosyl hydroxylysine in urine as a means for the identification of osteoporotic women.
    Moro L; Modricky C; Rovis L; de Bernard B
    Bone Miner; 1988 Jan; 3(3):271-6. PubMed ID: 3207948
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Age-related and menopause-related changes of urinary excretion of C- and N-terminal cross-linked telopeptides of type I collagen and the relationships thereof with menopause-related bone loss].
    Liu SP; Liao EY; Wu XP; Cao XZ; Shan PF; Su X
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):371-5. PubMed ID: 16677543
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased urinary excretion of collagen crosslinks in girls with Ullrich-Turner syndrome.
    Rauch F; Seibel M; Woitge H; Kruse K; Schönau E
    Acta Paediatr; 1995 Jan; 84(1):66-9. PubMed ID: 7734903
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
    Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
    J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
    Kumeda Y; Inaba M; Tahara H; Kurioka Y; Ishikawa T; Morii H; Nishizawa Y
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4157-61. PubMed ID: 11095447
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relation of parity and homocysteine to bone mineral density of postmenopausal women.
    Yilmaz N; Kepkep N; Ciçek HK; Celik A; Meram I
    Clin Lab; 2006; 52(1-2):49-56. PubMed ID: 16506364
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of modifying dietary calcium intake pattern on the circadian rhythm of bone resorption.
    Aerssens J; Declerck K; Maeyaert B; Boonen S; Dequeker J
    Calcif Tissue Int; 1999 Jul; 65(1):34-40. PubMed ID: 10369731
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment and recommendations on factors contributing to preanalytical variability of urinary pyridinoline and deoxypyridinoline.
    Vesper HW; Demers LM; Eastell R; Garnero P; Kleerekoper M; Robins SP; Srivastava AK; Warnick GR; Watts NB; Myers GL
    Clin Chem; 2002 Feb; 48(2):220-35. PubMed ID: 11805003
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic value of urinary pyridinium crosslinks and their derivatives in multiple myeloma.
    Samani KK; Brazier M; Mathiot C; Kamel S; Jamart J; Jaubert J; Blanc M; Azaïs I; Facon T; Leleu X
    Ann Hematol; 2005 Jan; 84(1):19-24. PubMed ID: 15338198
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-performance liquid chromatographic method for measuring hydroxylysine glycosides and their ratio in urine as a possible marker of human bone collagen breakdown.
    Grazioli V; Casari E; Murone M; Bonini PA
    J Chromatogr; 1993 May; 615(1):59-66. PubMed ID: 8340463
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Biochemical bone marrow markers and their significance in postmenopausal osteoporosis--a new method in the diagnosis of osteoporosis?].
    Heiss C; Keller T; Wehr U; Mohr A; Lommel D; Meyer Ch; Rambeck WA; Schnettler R
    Biomed Tech (Berl); 2004 Oct; 49(10):282-9. PubMed ID: 15566078
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of an oral calcium load on urinary markers of collagen breakdown.
    Rubinacci A; Divieti P; Polo RM; Zampino M; Resmini G; Tenni R
    J Endocrinol Invest; 1996 Dec; 19(11):719-26. PubMed ID: 9061504
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of an immunoassay for urinary galactosylhydroxylysine.
    Leigh SD; Ju HS; Lundgard R; Daniloff GY; Liu V
    J Immunol Methods; 1998 Nov; 220(1-2):169-78. PubMed ID: 9839938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.